AptaBio Therapeutics Inc (293780) — Net Asset Momentum
AptaBio Therapeutics Inc (293780) recorded a net asset momentum of -11.7% as of December 2024, with net assets of ₩54.20 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check tangible equity quality of AptaBio Therapeutics Inc to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
AptaBio Therapeutics Inc Net Asset Momentum (2017–2024)
This chart tracks AptaBio Therapeutics Inc's year-over-year net asset growth across 8 annual reporting periods from 2017 to 2024. The most recent momentum reading is -11.7%, with net assets of ₩54.20 Billion KRW as of December 2024. Read AptaBio Therapeutics Inc total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for AptaBio Therapeutics Inc (2017–2024)
The table below shows the complete annual net asset history for AptaBio Therapeutics Inc from 2017 to 2024, covering 8 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see market value of AptaBio Therapeutics Inc.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | ₩54.20 Billion | ₩77.43 Billion | ₩23.24 Billion | ▼ -11.7% |
| 2023 | ₩61.36 Billion | ₩92.52 Billion | ₩31.16 Billion | ▲ +17.2% |
| 2022 | ₩52.37 Billion | ₩56.11 Billion | ₩3.74 Billion | ▼ -15.1% |
| 2021 | ₩61.67 Billion | ₩64.91 Billion | ₩3.25 Billion | ▼ -14.4% |
| 2020 | ₩72.04 Billion | ₩75.44 Billion | ₩3.40 Billion | ▼ -4.1% |
| 2019 | ₩75.16 Billion | ₩77.40 Billion | ₩2.25 Billion | ▲ +310.4% |
| 2018 | ₩18.31 Billion | ₩20.33 Billion | ₩2.02 Billion | ▲ +158.1% |
| 2017 | ₩-31.54 Billion | ₩11.00 Billion | ₩42.54 Billion | — |